On ECHEMI
Home > Drugs > Haisco Pharmaceutical(Meishan) Co., Ltd.
Haisco Pharmaceutical(Meishan) Co., Ltd.
  • Founded in:

    2019-11-14
  • Country:

    China China
  • Address:

    No. 53, South Section of Shunjiang Avenue, East District, Economic Development Zone, Meishan City, Sichuan Province
  • Tax NO.:

    91511402MA6AXG1C5Y
  • Registered Funds:

    290 million yuan
  • Website:

  • Email:

Related Drugs
Pramipexole Hydrochloride Extended Release Tablets
Main ingredients of this product: Pramipexole hydrochloride
Name Description Content CAS NO. Registered Holders
Pramipexole dihydrochloride monohydrate

It is a dopamine receptor agonist that binds to the dopamine receptor D2 subfamily with high selectivity and specificity, with preferential affinity for the D3 receptor; and has full intrinsic activity. It relieves movement disorders in patients with Parkinson's disease by stimulating dopamine receptors in the striatum. It inhibits the synthesis, release and renewal of dopamine. It can protect dopamine neurons from degeneration caused by ischemia or methamphetamine neurotoxicity. It can protect neurons from neurotoxicity caused by levodopa. Dose-dependent prolactin reduction was observed in volunteers.

More

It is a dopamine receptor agonist that binds to the dopamine receptor D2 subfamily with high selectivity and specificity, with preferential affinity for the D3 receptor; and has full intrinsic activity. It relieves movement disorders in patients with Parkinson's disease by stimulating dopamine receptors in the striatum. It inhibits the synthesis, release and renewal of dopamine. It can protect dopamine neurons from degeneration caused by ischemia or methamphetamine neurotoxicity. It can protect neurons from neurotoxicity caused by levodopa. Dose-dependent prolactin reduction was observed in volunteers.

191217-81-9 43
Flupentixol Hydrochloride
Name Description Content CAS NO. Registered Holders
cis-Flupentixol hydrochloride

Extract from the above information

More

Extract from the above information

51529-01-2 6
Rupatadine Fumarate Tablets
The main ingredient is rupatadine fumarate.
Name Description Content CAS NO. Registered Holders
Rupatadine Fumarate

182349-12-8 19
Rupatadine Fumarate
Name Description Content CAS NO. Registered Holders
Rupatadine Fumarate

Extract from the above information

More

Extract from the above information

182349-12-8 19
Tenofovir Disoproxil Fumarate Tablets
The main ingredient of this product is tenofovir disoproxil fumarate, and its chemical name is: 9-((R)-2-((bis(((isopropoxycarbonyl)oxy(methoxy)phosphinyl)-propyl)adenine fumarate (1:1). Chemical structure: Molecular formula: C19H30N5O10.C4H4O4 Molecular weight: 635.52
Name Description Content CAS NO. Registered Holders
Tenofovir disoproxil fumarate

Tenofovir disoproxil fumarate is a ring-opening nucleoside phosphinated diester analog of adenosine monophosphate. It forms tenofovir diphosphate through phosphorylation by cellular enzymes, which can terminate DNA synthesis and inhibit the activity of HIV-1 reverse transcriptase and HBV reverse transcriptase. It is a weak inhibitor of mammalian DNA polymerase and mitochondrial DNA polymerase.

More

Tenofovir disoproxil fumarate is a ring-opening nucleoside phosphinated diester analog of adenosine monophosphate. It forms tenofovir diphosphate through phosphorylation by cellular enzymes, which can terminate DNA synthesis and inhibit the activity of HIV-1 reverse transcriptase and HBV reverse transcriptase. It is a weak inhibitor of mammalian DNA polymerase and mitochondrial DNA polymerase.

202138-50-9 70
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.